• Busca persones
• Intranet

Informàtica biomèdica integrada Ferran Sanz

Publicacions 2024 (13)

• Mercadé-Besora N, Guo Y, Du M, Li X, Ramírez-Anguita JM, Moreno A, Valente A, Villalobos F, Cheng IL, Carrasco-Ribelles LA, van Swieten M, Merkelbach M, Magoya M, Lasalvia P, Pericàs-Pulido P, Berg P, Bosco-Lévy P, Lillini R, Ribeiro R, Bagga TK, Ramella V, Khalid S, Mayer MA, Leis A, Jödicke AM, Burn E, Prieto-Alhambra D^*, Català M, Prats A. Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic. Arthrit Care Res 2024: (en Premsa).
• Du M, Dernie F, Català M, Delmestri A, Man WY, Brash JT, Van Ballegooij H, Mercadé-Besora N, Duarte-Salles T, Mayer MA, Leis A, Ramírez-Anguita JM, Griffier R, Verdy G, Prats A, Pacurariu A, Morales DR, De Lisa R, Galluzzo S, Egger GF, Prieto-Alhambra D^*, Tan EH. Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries. Eur J Intern Med 2024: (en Premsa).
• La Chica Lhöest M.T, Martinez A, Claudi L, Garcia E, Benitez Amaro A, Polishchuk A, Piñero J, Viladés-Medel D, Guerra JM, Sanz F, Rotllan N, Escolà-Gil JC, Llorente-cortés V^*. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Front Cardiovasc Med . 2024; 11: (Acceptat).
• Mortier P^*, Conde S, Alayo I, Amigo F, Ballester L, Cirici MR, Guinart D, Contaldo SF, Ferrer M, Leis A, Mayer MA, Portillo-Van Diest A, Puértolas B, Ramírez-Anguita JM, Peña CM, Sanz F, Kessler RC, Palao D, Pérez V, Mehlum L, Qin P, Vilagut G^*, Alonso J. Premature Death, Suicide, and Nonlethal Intentional Self-Harm After Psychiatric Discharge. JAMA Netw Open 2024; 7(6): .
• Gualdi F^*, Oliva B, Piñero J. Genopyc: a Python library for investigating the functional effects of genomic variants associated to complex diseases. Bioinformatics 2024; 40(6): btae379.
• Burkard T, López-Güell K, Gorbachev A, Bellas L, Jödicke AM, Burn E, de Ridder M, Mosseveld M, Gratton J, Seager S, Vojinovic D, Mayer MA, Ramírez-Anguita JM, Leis A, Oja M, Kolde R, Bonadt K, Prieto-Alhambra D^*, Reich C, Català M. Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model. Pharmacoepidemiol Drug Saf 2024; 33(6): e5809.
• Gualdi F, Oliva B, Piñero J^*. Predicting gene disease associations with knowledge graph embeddings for diseases with curtailed information. NAR Genomics and Bioinformatics 2024; 6(2): lqae049 (Acceptat).
• Niarakis A^*, Ostaszewski M, Mazein A, Kuperstein I, Kutmon M, Gillespie ME, Funahashi A, Acencio ML, Hemedan A, Aichem M, Klein K, Czauderna T, Burstscher F, Yamada TG, Hiki Y, Hiroi NF, Hu F, Pham N, Ehrhart F, Willighagen EL, Valdeolivas A, Dugourd A, Messina F, Esteban-Medina M, Peña-Chilet M, Rian K, Soliman S, Aghamiri SS, Puniya BL, Naldi A, Helikar T, Singh V, Fariñas-Fernández M, Bermudez V, Tsirvouli E, Montagud A, Noël V, Ponce de Leon M, Maier D, Bauch A, Gyori BM, Bachman JA, Luna A, Piñero J, Furlong LI, Balaur I, Rougny A, Jarosz Y, Overall RW, Phair R, Perfetto L, Matthews L, Rex DAB, Orlic-Milacic M, Monraz-Gomez LC, De Meulder B, Ravel JM, Jassal B, Satagopam V, Wu G, Golebiewski M, Gawron P, Calzone L, Beckmann JS, Evelo CT, D'Eustachio P, Schreiber F, Saez-Rodriguez J, Dopazo J, Kuiper M, Valencia A, Wolkenhauer O, Kitano H, Barillot E, Auffray C, Balling R, Schneider R, COVID-19 Disease Map Community. Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches. Front Immunol 2024; 14: 1282859 (Acceptat).
• Baune BT^*, Minelli A, Carpiniello B, Contu M, Domínguez J, Donlo MJ, Ferensztajn-Rochowiak E, Glaser R, Kelch B, Kobelska P, Kolasa G, Kopec D, Martínez de Lagrán M, Martini P, Mayer MA, Menesello V, Paribello P, Perera J, Perusi G, Pinna F, Pinna M, Pisanu C, Sierra C, Stonner I, Wahner VTH, Xicota L, Zang JCS, Gennarelli M, Manchia M, Squassina A, Potier MC, Rybakowski F, Sanz F, Dierssen M. An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response. Front Psychiatry 2024; 14: 1279688 (Acceptat).
• Mortier P^*, Vilagut G, García-Mieres H, Alayo I, Ferrer M, Amigo F, Aragonès E, Aragón-Peña A, Asunsolo A, Campos M, Espuga M, González-Pinto A, Haro JM, López Fresneña, Martínez de Salázar A, Molina JD, Ortí-Lucas R.M., Parellada M, Pelayo-Terán JM, Pérez Gómez B, Pérez Zapata A, Pijoan JI, Plana N, Polentinos E, Portillo-Van Diest A, Puig T, Rius C, Sanz F, Serra C, Urreta-Barallobre I, Kessler RC, Bruffaerts R, Vieta E, Pérez V, Alonso J, MINDCOVID Working group. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic - A prospective cohort study using web-based surveys. Psychiat Res 2024; 334: 115800.
• Giannoula A^*, Comas M, Castells X, Estupiñán-Romero F, Bernal-Delgado E, Sanz F, Sala M^*. Exploring long-term breast cancer survivors' care trajectories using dynamic time warping-based unsupervised clustering. J Am Med Inform Assn 2024; 31(4): 820-831.
• Mortier P^*, Amigo F, Bhargav M, Conde S, Ferrer M, Flygare O, Kizilaslan B, Latorre-Moreno L, Leis A, Mayer MA, Pérez V, Portillo-Van Diest A, Ramírez-Anguita JM, Sanz F, Vilagut G, Alonso J, Mehlum L, Arensman E, Bjureberg J, Pastor M, Qin P. Developing a clinical decision support system software prototype that assists in the management of patients with self-harm in the emergency department: protocol of the PERMANENS project. BMC Psychiatry 2024; 24(1): 220.
• Velasco T^*, Trincado JL, Vinyoles M, Closa A, Martinez-Moreno A, Gutiérrez F, Molina O, Rodriguez-Cortez VC, Ximeno-Parpal P, Fernandez-Fuentes N, Petazzi P, Beneyto-Calabuig S, Velten L, Romecin P, Casquero R, Abollo-Jimenez F, Diaz de la Guardia R, Lorden P, Bataller A, Lapillonne H, Stam RW, Vives S, Torrebadell M, Fuster JL, Bueno C, Sarry JE, Eyras E, Heyn H, Menéndez P^*. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Hemasphere . 2024; 8(2): e45 (Acceptat).